Sedation for endoscopy: the safe use of propofol by general practitioner sedationists

  title={Sedation for endoscopy: the safe use of propofol by general practitioner sedationists},
  author={Anthony C. Clarke and Louise Chiragakis and L Hillman and Graham L. Kaye},
  journal={Medical Journal of Australia},
Objective: To determine the incidence of adverse events related to an endoscopy sedation regimen that included propofol, delivered by general practitioner (GP) sedationists. 
Conscious sedation using propofol versus midazolam in cirrhotic patients during upper GI endoscopy: A comparative study
We aimed to assess the safety and efficacy of propofol versus midazolam in cirrhotic patients undergoing upper GI endoscopy.
Efficiency issues in sedation and monitoring.
  • C. Wilcox
  • Medicine
    Gastrointestinal endoscopy clinics of North America
  • 2004
The current practices of sedation and monitoring in endoscopy will likely change in the future with technologic advances (monitoring) and expansion of the pharmacologic armamentarium (sedation).
Sedation and the technical performance of colonoscopy.
The technical performance of Colonoscopy in patients who undergo unsedated colonoscopy, sedation with narcotics and benzodiazepines, and deep sedationWith propofol is reviewed.
Risk factors for cardiopulmonary events during propofol‐mediated upper endoscopy and colonoscopy
Propofol‐mediated sedation for endoscopy is popular because of its rapid onset and recovery profile.
Gastroenterologist-directed propofol: an update.
Gastroenterologist directed propofol has been proven safe in more than 220,000 published cases. Administration of low doses of opioid and/or benzodiazepine ("balanced propofol sedation") is the
Efficacy and safety of using premedication with simethicone/Pronase during upper gastrointestinal endoscopy examination with sedation: A single center, prospective, single blinded, randomized controlled trial
To investigate the efficacy and safety of premedication with simethicone/Pronase during esophagogastroduodenoscopy (EGD) with sedation.
Optimal sedation for gastrointestinal endoscopy: Review and recommendations
There is evidence presented to indicate that non‐anesthetists can administer sedative drugs, including propofol, safely and efficaciously in selected cases, and possible future directions in this area are briefly summarized.
Sedation in endoscopic practice.
New developments in endoscopic sedation and their implications for practice management are discussed.
Propofol for endoscopic sedation: A protocol for safe and effective administration by the gastroenterologist.
It is believed that propofol, potentiated by small doses of midazolam and meperidine, can be safely and effectively administered under the direction of a gastroenterologist.
Sedation in endoscopy: when and how.
Sedation for endoscopy provides comfort for the patient and better examination conditions for the endoscopist and several conditions have to be fulfilled to provide proper and safe non-anaesthesiologist sedation forendoscopy, especially when propofol is to be used.


Sedation for endoscopy.
A review of the recent literature reveals an increasing published opinion in favour of unsedated endoscopy. However, recent studies show that the majority of US patients are unwilling or unable to
Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods.
A prospective audit of upper gastrointestinal endoscopy in 36 hospitals across two regions provided data from 14,149 gastroscopies of which 1113 procedures were therapeutic and 13,036 were diagnostic, and there was a link between the use of local anaesthetic sprays and the development of pneumonia after gastroscopy.
Synergistic sedation with low-dose midazolam and propofol for colonoscopies.
Low-dose midazolam combined with propofol is an effective and economic alternative to benzodiazepine-based analgosedation and has a potential cost benefit concerning nursing care and bed facilities.
Propofol and midazolam act synergistically in combination.
Dose-response curves for propofol and midazolam alone and in combination for hypnosis and anaesthesia were determined and synergistic interaction was found, but the cause of the synergism was not clear, but may have been interaction at CNS GABAA receptors.
Midazolam acts synergistically with fentanyl for induction of anaesthesia.
Midazolam was found to act in synergism with fentanyl for induction of anaesthesia and this degree of synergism may explain mutual potentiation between opioids and benzodiazepines reported previously.
American Society of Anesthesiologists Physical Status Classification System in not a risk classification system.
The American Society of Anesthesiologists Physical Status Classification System Is Not a Risk Classification System and is not a risk classification system, according to a study published in The Lancet Anesthesiology.
a prospective, controlled trial
  • Gastrointest Endosc 1999; 49: 677-683.
  • 2001
Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled trial
  • Gastrointest Endosc
  • 1999
Medicare Benefits Schedule Group Statistics for Medicare items 30473 , 30484 , 30485 , 30491 , 32090 , 32093 and 41819 . July 1999 to Jun 2000
  • 1997